148 related articles for article (PubMed ID: 14744536)
1. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
Himmelfarb M; Klopocki E; Grube S; Staub E; Klaman I; Hinzmann B; Kristiansen G; Rosenthal A; Dürst M; Dahl E
Cancer Lett; 2004 Feb; 204(1):69-77. PubMed ID: 14744536
[TBL] [Abstract][Full Text] [Related]
2. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
3. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
Veeck J; Breuer E; Rose M; Chorovicer M; Naami A; Bektas N; Alkaya S; von Serényi S; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():338-46. PubMed ID: 18810445
[TBL] [Abstract][Full Text] [Related]
4. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
[TBL] [Abstract][Full Text] [Related]
5. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
Mai C; Zhao JJ; Tang XF; Wang W; Pan K; Pan QZ; Zhang XF; Jiang SS; Zhao BW; Li YF; Xia JC; Zhou ZW
Med Oncol; 2014 Jul; 31(7):53. PubMed ID: 24913813
[TBL] [Abstract][Full Text] [Related]
6. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.
Hamm A; Veeck J; Bektas N; Wild PJ; Hartmann A; Heindrichs U; Kristiansen G; Werbowetski-Ogilvie T; Del Maestro R; Knuechel R; Dahl E
BMC Cancer; 2008 Jan; 8():25. PubMed ID: 18226209
[TBL] [Abstract][Full Text] [Related]
7. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
Huth S; Heise R; Vetter-Kauczok CS; Skazik C; Marquardt Y; Czaja K; Knüchel R; Merk HF; Dahl E; Baron JM
Exp Dermatol; 2015 Sep; 24(9):663-8. PubMed ID: 25809190
[TBL] [Abstract][Full Text] [Related]
8. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
[TBL] [Abstract][Full Text] [Related]
9. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis combined with functional genomics approach identifies ITIH5 as tumor suppressor gene in cervical carcinogenesis.
Dittmann J; Ziegfeld A; Jansen L; Gajda M; Kloten V; Dahl E; Runnebaum IB; Dürst M; Backsch C
Mol Carcinog; 2017 Jun; 56(6):1578-1589. PubMed ID: 28059468
[TBL] [Abstract][Full Text] [Related]
11. Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin.
Huth S; Huth L; Marquardt Y; Fietkau K; Dahl E; Esser PR; Martin SF; Heise R; Merk HF; Baron JM
Skin Pharmacol Physiol; 2020; 33(4):198-206. PubMed ID: 32799206
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
Sasaki K; Kurahara H; Young ED; Natsugoe S; Ijichi A; Iwakuma T; Welch DR
Clin Exp Metastasis; 2017 Apr; 34(3-4):229-239. PubMed ID: 28289921
[TBL] [Abstract][Full Text] [Related]
13. ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro.
Rose M; Huth S; Wiesehöfer M; Ehling J; Henkel C; Steitz J; Lammers T; Kistermann J; Klaas O; Koch M; Rushrush S; Knüchel R; Dahl E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158755
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Rose M; Gaisa NT; Antony P; Fiedler D; Heidenreich A; Otto W; Denzinger S; Bertz S; Hartmann A; Karl A; Knüchel R; Dahl E
Carcinogenesis; 2014 Mar; 35(3):727-36. PubMed ID: 24265292
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia.
Oing C; Jost E; Dahl E; Wilop S; Brümmendorf TH; Galm O
Clin Epigenetics; 2011 Aug; 2(2):419-23. PubMed ID: 22704354
[TBL] [Abstract][Full Text] [Related]
16. Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma.
Chen M; Ma J; Xie X; Su M; Zhao D
Cancer Sci; 2024 May; 115(5):1665-1679. PubMed ID: 38475675
[TBL] [Abstract][Full Text] [Related]
17. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
Liu J; Cao F; Li X; Zhang L; Liu Z; Li X; Lin J; Han C
Cell Death Dis; 2021 May; 12(5):438. PubMed ID: 33935281
[TBL] [Abstract][Full Text] [Related]
18. Detection of novel genes that are up-regulated (Di12) or down-regulated (T1A12) with disease progression in breast cancer.
Burger AM; Zhang X; Seth A
Eur J Cancer Prev; 1998 Feb; 7 Suppl 1():S29-35. PubMed ID: 10866033
[TBL] [Abstract][Full Text] [Related]
19. Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.
Sierko E; Wojtukiewicz MZ; Ostrowska-Cichocka K; Zimnoch L
Thromb Haemost; 2010 Jul; 104(1):183-5. PubMed ID: 20458435
[No Abstract] [Full Text] [Related]
20. ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
Peng K; Ding D; Wang N; Du T; Wang L; Duan X
Mol Omics; 2023 Oct; 19(9):714-725. PubMed ID: 37431189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
